Found 1717 results
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
Z. Wu, Tang, Z., Mao, Y., Van Veldhuisen, P., Ling, W., Liu, D., Shen, Z., Detels, R., Lan, G., Erinoff, L., Lindblad, R., Gu, D., Tang, H., Hu, L., Zhu, Q., Lu, L., Oden, N., Hasson, A. L., Zhao, Y., McGoogan, J. M., Ge, X., Zhang, N., Rou, K., Zhu, J., Wei, H., Shi, C. X., Jin, X., Li, J., and Montaner, J. S. G., Testing and Linkage to HIV Care in China: A Cluster-Randomised Trial, Lancet HIV, vol. 4, no. 12, pp. e555-e565, 2017.
L. - T. Wu, McNeely, J., Subramaniam, G. A., Brady, K. T., Sharma, G., VanVeldhuisen, P., Zhu, H., and Schwartz, R. P., DSM-5 Substance Use Disorders Among Adult Primary Care Patients: Results from a Multisite Study, Drug Alcohol Depend, vol. 1, no. 179, pp. 42-46, 2017.
L. T. Wu, McNeely, J., Subramaniam, G. A., Sharma, G., Van Veldhuisen, P., and Schwartz, R. P., Design of the NIDA Clinical Trials Network Validation Study of Tobacco, Alcohol, Prescription Medications, and Substance Use/Misuse (TAPS) Tool, Contemp Clin Trials, vol. 50, pp. 90-97, 2016.
L. Wu, Brady, K. T., Spratt, S. E., Dunham, A. A., Heidenfelder, B., Batch, B. C., Lindblad, R., VanVeldhuisen, P., Rusincovitch, S. A., Killeen, T. K., and Ghitza, U. E., Using Electronic Health Record Data for Substance Use Screening, Brief Intervention, and Referral to Treatment Among Adults with Type 2 Diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network Study, Contemp Clin Trials, vol. 46, pp. 30-38, 2016.
A. Domalpally, Clemons, T. E., Danis, R. P., Sadda, S. V. R., Cukras, C. A., Toth, C. A., Friberg, T. R., and Chew, E. Y., Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: AREDS 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Group, Ophthalmology, vol. 124, no. 4, pp. 479-487, 2017.
J. Wright, Hillsamer, V. L., Gore-Langton, R. E., and Cheson, B. D., Clinical Trials Referral Resource. Current Clinical Trials for the Proteasome Inhibitor PS-341, Oncology, vol. 14, no. 11, pp. 1589-15901593-941597, 2000.
P. F. Wright, Mestecky, J., McElrath, M. J., Keefer, M. C., Gorse, G. J., Goepfert, P. A., Moldoveanu, Z., Schwartz, D., Spearman, P. W., R Habib, E., Spring, M. D., Zhu, Y., Smith, C., Flores, J., and Weinhold, K. J., Comparison of Systemic and Mucosal Delivery of 2 Canarypox Virus Vaccines Expressing Either HIV-1 Genes or the Gene for Rabies Virus G Protein, J Infect Dis, vol. 189, no. 7, pp. 1221-1231, 2004.
P. F. Wright, Lambert, J. S., Gorse, G. J., Hsieh, R. H., McElrath, M. J., Weinhold, K., Ware, D. W., Anderson, E. L., Keefer, M. C., Jackson, S., Wagner, L. J., Francis, D. P., Fast, P. E., and McNamara, J., Immunization with Envelope MN rap 120 Vaccine in Human Immunodeficiency Virus Infected Pregnant Women, J Infec Dis, vol. 180, no. 4, pp. 1080-1088, 1999.
B. L. Wright, Kulis, M., Orgel, K. A., Burks, A. W., Dawson, P., Henning, A. K., Jones, S. M., Wood, R. A., Sicherer, S. H., Lindblad, R. W., Stablein, D., Leung, D. Y. M., Vickery, B. P., and Sampson, H. A., Component-Resolved Analysis of IgA, IgE, and IgG4 During Egg OIT Identifies Markers Associated with Sustained Unresponsiveness, Allergy, vol. 71, no. 11, pp. 1552-1560, 2016.
M. Wright, Lindblad, R., Jelstrom, E., King, D., Blumberg, D., Yohannes, P., Yesko, L., Campanella, M., and Saunders, C. A., Implementation of a Medication and Supply Inventory and Resupply Process - Increasing the Efficiency of the Tracking and Distribution of Supplies in Clinical Trials, in Society for Clinical Trials (SCT) 36th Annual Meeting (2015), Arlington, VA, 2015.
E. Woodle and Van Veldhuisen, P., A Prospective, Randomized, Multicenter, Double-Blind Study of Early Corticosteroid Cessation Versus Long-Term Maintenance of Corticosteroid Therapy with Tacrolimus and Mycophenolate Mofetil in Primary Renal Transplant Recipients: One Year Report, Transplant Proc, vol. 37, no. 2, pp. 804-808, 2005.
E. S. Woodle, A Randomized, Double Blind, Placebo Controlled Trial of Early Corticosteroid Cessation vs Chronic Corticosteroid Maintenance Therapy, in American Transplant Congress (ATC), Philadelphia, PA, 2005.
E. S. Woodle, A Prospective, Randomized, Double Blind, Multicenter Trial of Early (7 Day) Corticosteroid Cessation vs Long Term Low Dose Corticosteroid Therapy Under Tacrolimus and Mycopheonlate Mofetil Therapy with Antibody Induction, in American Transplant Congress (ATC), 2003.
E. S. Woodle, A Randomized, Double Blind, Placebo Controlled Trial of Early Corticosteroid Cessation vs. Chronic Corticosteroid Maintenance Therapy, in American Transplant Congress (ATC), Philadelphia, PA, 2004.
S. Woodle, First, M. R., Pirsch, J., Shihab, F., Gaber, A. O., and Van Veldhuisen, P., A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy, Ann Surg, vol. 248, no. 4, pp. 564-577, 2008.
R. A. Wood, Sicherer, S. H., Vickery, B. P., Jones, S. M., Liu, A. H., Fleischer, D. M., Henning, A. K., Mayer, L., Burks, A. W., Grishin, A., Stablein, D., and Sampson, H. A., The Natural History of Milk Allergy in an Observational Cohort, J Allergy Clin Immunol, vol. 131, pp. 805-812, 2013.
R. Wood, Sicherer, S., Stablein, D., Jones, S., Burks, A., Liu, A., Fleischer, D., Leung, D., Lindblad, R., and Sampson, H., Trends in Milk, Egg, and Peanut IgE Levels Over Time in an Observational Study of Infants with Food Allergy (COFAR2): One Year Follow Up, in Annual Meeting of the American Academy of Allergy, Asthma, and Immunology, Washington DC, 2009.
R. A. Wood, Kim, J. S., Lindblad, R., Nadeau, K., Henning, A. K., Dawson, P., Plaut, M., and Sampson, H. A., A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab Combined with Oral Immunotherapy for the Treatment of Cow's Milk Allergy, J Allergy Clin Immunol, vol. 137, no. 4, pp. 1103-10.e1-11, 2016.
R. A. Wood, Stablein, D., Henning, A. K., Lindblad, R., and Sicherer, S. H., A Phase 1 Study of Heat/Phenol Killed, E. coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the Treatment of Peanut Allergy, in AAAAI - American Academy of Allergy, Asthma & Immunology, Orlando, FL, 2012, vol. 129(2), p. AB27.
R. A. Wood, Sicherer, S. H., Burks, A. W., Grishin, A., Henning, A. K., Lindblad, R., Stablein, D., and Sampson, H. A., A Phase 1 Study of Heat/Phenol-Killed, E. coli - Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the Treatment of Peanut Allergy, Allergy, vol. 68, pp. 803-808, 2013.
W. T. Wong, Liang, K., Hammel, K., Coleman, H. R., and Chew, E. Y., Intravitreal Ranibizumab Therapy for Retinal Capillary Hemangioblastoma Related to von Hippel-Lindau Disease, Ophthalmology, vol. 115, pp. 1957-1964, 2008.
W. Wong, Kam, W., Cunningham, D., Harrington, M., Hammel, K., Meyerle, C., Cukras, C., Chew, E., Sadda, S., and Ferris, F., Treatment of Geographic Atrophy by the Topical Administration of OT-551: Results of a Phase II Clinical Trial, Invest Ophthlmol Vis Sci, vol. 51, pp. 613-619, 2010.
W. T. Wong, Dresner, S., Forooghian, F., Glaser, T., Doss, L., Zhou, M., Cunningham, D., Shimel, K., Harrington, M., Hammel, K., Cukras, C., Ferris, F. L., and Chew, E. Y., Treatment of Geographic Atrophy with Subconjunctival Sirolimus: Results of a Phase I/II Clinical Trial, Invest Ophthalmol Vis Sci, vol. 54, pp. 2941-2950, 2013.
Y. J. Wong, Keenan, J., Hudson, K., Bryan, H., Naftolin, F., Thompson, V. P., Craig, R. G., Vena, D., Collie, D., Wu, H., Matthews, A. G., Grill, A. C., and Curro, F. A., Opioid, NSAID, and OTC Analgesic Medications for Dental Procedures: PEARL Network Findings, Compend Contin Educ Dent, vol. 37, no. 10, pp. 710-718, 2016.